BioSpace News Archive

Vertos Medical Inc., a leader in the development of innovative, minimally invasive treatments for lumbar spinal stenosis, announced that the Centers for Medicare and Medicaid Services has increased Ambulatory Surgery Center reimbursement for the mild® Procedure.

Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians and pharmaceutical companies, and Alnylam Pharmaceuticals, Inc. (“ Alnylam ”), the leading RNAi therapeutics company, announced today the launch of a new joint clinical screening program: the genetic scre

Cerevel Therapeutics (Nasdaq: CERE), a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases, announced today that it has added Ruth McKernan, Ph.D., CBE, FMedSci, to serve as an independent member of its Board of Directors. Dr. McKernan currently serves as a venture partner with SV Health Investors, LLP, a global investment firm and specialist healthcare fund manager, where she supports companies that cr

Adicet Bio, Inc. (Nasdaq: ACET), a biotechnology company discovering and developing first-in-class allogeneic gamma delta T cell therapies for cancer and other diseases, today announced that Chen Schor, President and Chief Executive Officer and Stewart Abbot, Ph.D., Chief Scientific and Operating Officer, will participate in a fireside chat at The JMP Securities Hematology Summit on Tuesday, December 15, 2020 at 2:00 PM ET. A live audio w

EZaccessMD is the first and only mobile, employer-based subscription telehealth provider that brings rapid diagnostics right to the patient’s home. Today, the company announced an additional exclusive offering – rapid mobile in-home COVID-19 testing.

Eli Lilly and Company (NYSE: LLY) will announce its financial guidance for 2021 on Tuesday, December 15, 2020 . Lilly will also conduct a conference call on that day with the investment community and media to further detail the company’s financial guidance. The conference call will begin at 8:30 a.m. Eastern time . Investors, me

Orchard Therapeutics (Nasdaq: ORTX), a global gene therapy leader, yesterday reported initial data from an ongoing proof-of-concept clinical trial evaluating the safety and efficacy of OTL-201, an investigational ex vivo autologous hematopoietic stem cell (HSC) gene therapy being studied for the treatment of mucopolysaccharidosis type IIIA (MPS-IIIA, also known as Sanfilippo syndrome type A). The data were presented as part of an oral pres

Cerecor Inc. (NASDAQ: CERC), a biopharmaceutical company focused on becoming a leader in development and commercialization of treatments for rare and orphan diseases, today announced that its Investigational New Drug Application (IND) to study the use of CERC-007 to treat relapsed or refractory multiple myeloma (MM) has been accepted by the United States Food and Drug Administration (FDA) and is now open. The first study w

Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of several eye disorders, announced today that Mina Sooch, Chief Executive Officer, Charlie Hoffmann, VP of Corporate Development and Operations, and Amy Rabourn, VP of Finance will be participating in a fireside chat hosted by Kristen Kluska, Equity Research Analyst at Cantor Fitzgerald, on

Ocular Partners, Inc., the premier physician-led eye care group in greater Chicago, is pleased to announce an agreement with two ophthalmology practices - University Ophthalmology in Hyde Park, previously owned by Dr. Veena Arun and Lakeshore Eye Physicians, previously owned by Dr. Howard Reinglass.